Indigo appoints Dr. Mehmood Khan, MD, PepsiCo’s Vice Chairman and Chief Scientific Officer, to Board of Directors
- Esteemed leader responsible for sustainable innovations in the food industry to join Indigo
- Indigo’s Board grows to six industry experts, poised to help drive company growth
Boston, Massachusetts, July 12, 2017 – Indigo Ag, Inc., a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces today the appointment of Dr. Mehmood Khan, Vice Chairman and Chief Scientific Officer of PepsiCo, to its Board of Directors. Alongside other members, Dr. Khan will help support the company’s mission with his years of experience leading innovative and sustainable agriculture and nutrition initiatives.
“It’s an honor to be a part of Indigo and its impressive team as they redefine what it means to be an agriculture company today,” said Dr. Khan. “Not only is this startup defined by its cutting-edge research and technology, but also by its proven commitment to growers, consumers, and the environment.”
As Chief Scientific Officer of Global Research and Development at PepsiCo, Dr. Khan oversees PepsiCo’s global Performance with Purpose sustainability initiatives, inspired by the fundamental belief that business success is inextricably linked to the sustainability of the world we share. In his role leading PepsiCo’s research and development efforts, Dr. Khan develops novel technologies in food and beverage products, nutrition, manufacturing, packaging, and distribution. Dr. Khan is also Chair of PepsiCo’s Sustainability Council, where he oversees the company’s three core priorities: helping to improve health and well-being through the products they sell, protecting the planet, and empowering people around the world.
Before his role at PepsiCo, Dr. Khan led Takeda Pharmaceuticals Company’s worldwide research and development efforts as President of Takeda Global Research & Development Center. Dr. Khan also has extensive medical experience in diabetes, endocrinology, metabolism, and nutrition, having served as a faculty member at the Mayo Clinic and Mayo Medical School, as well as the Director of the Diabetes, Endocrine, and Nutritional Trials Unit in Mayo’s endocrinology division.
Dr. Khan joins industry leaders Robert Berendes, David Perry, John Gehring, Peter Innes, and Ignacio Martinez on Indigo’s Board of Directors.
“Dr. Khan is celebrated for pushing the boundaries of innovation while championing sustainability. We are honored to have him join Indigo’s Board of Directors,” said Robert Berendes, Indigo’s Chairman. “We are confident that Dr. Khan’s unique experience and knowledge will further advance our commitment to helping farmers sustainably feed the planet.”
Indigo is a company dedicated to harnessing nature to help farmers sustainably feed the planet. The company utilizes beneficial microbes residing within plant tissues to improve crop health and productivity. Indigo’s 2017 portfolio is focused on water use efficiency and yield in cotton, wheat, rice, corn, and soybeans. The company is headquartered in Boston, MA, with commercial and customer service based in Memphis, TN.